Literature DB >> 9165451

Active collagen synthesis by pulmonary arteries in pulmonary hypertension complicated by congenital diaphragmatic hernia.

T Yamataka1, P Puri.   

Abstract

The high mortality rate for patients with congenital diaphragmatic hernia (CDH) has been attributed to pulmonary hypoplasia and persistent pulmonary hypertension (PPH). The factors that cause vasoconstriction and vascular remodeling in PPH are not fully understood. Immunohistochemistry was performed on lung tissue obtained from postmortem CDH patients with pulmonary hypoplasia and PPH (n = 21) using the following antibodies: alpha smooth muscle-actin (ASMA), transforming growth factor-beta (TGF-beta), isoform specific (TGF-beta 1, -beta 2, -beta 3), and M-57. Normal lung tissues from age-matched sudden infant death syndrome patients (SIDS, n = 8) were obtained as controls. TGF-beta 3 immunoreactivity was observed in the adventitia but not in the media of pulmonary muscular arteries in patients with CDH. TGF-beta 1, -beta 2 immunoreactivity was either absent or faintly expressed in pulmonary arteries in CDH patients. No TGF-beta staining was observed in the pulmonary vasculature of SIDS patients. Newly synthesized procollagen (M-57) was easily detected in the media and adventitia in a large number of pulmonary arteries in all patients with CDH and in the neointima in two patients with long standing PPH. No M-57 staining was seen in the media of pulmonary arteries of the lungs of SIDS patients. These observations suggest a potential role of TGF-beta 3 but not TGF beta 1 or TGF beta 2 in pulmonary vascular remodeling and that smooth muscle cells in muscular pulmonary arteries are actively synthesizing collagen in patients with CDH complicated by PPH.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165451     DOI: 10.1016/s0022-3468(97)90005-1

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease.

Authors:  Wanli Ma; Weihong Han; Peter A Greer; Rubin M Tuder; Haroldo A Toque; Kevin K W Wang; R William Caldwell; Yunchao Su
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

2.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

3.  Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1: expression in the lung of fetal rats with nitrofen-induced diaphragmatic hernia.

Authors:  Y Tatekawa; H Kanehiro; M Hisanaga; Y Nakajima
Journal:  Pediatr Surg Int       Date:  2002-12-13       Impact factor: 1.827

4.  Decreased apelin and apelin-receptor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia.

Authors:  Alejandro D Hofmann; Florian Friedmacher; Hiromizu Takahashi; Manuela Hunziker; Jan-Hendrik Gosemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2014-02       Impact factor: 1.827

5.  Increased levels of circulating adhesion molecules in neonates with congenital diaphragmatic hernia complicated by persistent pulmonary hypertension.

Authors:  Hiroyuki Kobayashi; Atsuyuki Yamataka; Tadaharu Okazaki; Geoffrey J Lane; Prem Puri; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2003-12-13       Impact factor: 1.827

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.